Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Miller, A. Schaefer, B. Perry, N. Cook (Tofield, Lacombe, Canada). Nitric oxide gas: a potential respiratory antiviral. Eur Respir J 2005; 26: Suppl. 49, 1700

Member's Comments

No comment yet.

Related content which might interest you: Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide in reactive pulmonary hypertenzion Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012 Predicting response to corticosteroid in COPD using exhaled nitric oxide Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 The effect of bronchodilation and spirometry on exhaled nitric oxide Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Nitric oxide in primary ciliary dyskinesia}, Source: Eur Respir J 2012; 40: 1024-1032 Year: 2012 Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 The effect of ambient nitric oxide on exhaled nitric oxide measurement in children Source: Eur Respir J 2002; 20: Suppl. 38, 141s Year: 2002 The nitric oxide (NO) metabolites in monitoring and therapy of bronchial asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011 Potential for personalised application of inhaled nitric oxide in Covid-19 pneumonia Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond Year: 2021 Longitudinal variability of nasal nitric oxide measurements during winter Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Effect of smoking on exhaled nitric oxide and flow-independent nitric oxide exchange parameters Source: Eur Respir J 2006; 28: 339-345 Year: 2006 Fractional exhaled nitric oxide during acute viral bronchiolitis and future asthma at the age of four years Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Effective patient selection for PCD diagnostics; the PICADAR score with nasal nitric oxide Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood Year: 2016 Exhaled nitric oxide in mustard airway disease Source: International Congress 2018 – Occupational and environmental lung diseases: influence on the airway and interstitium Year: 2018 Data processing for steady-state models of multiple flow exhaled nitric oxide Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016 Exhaled nitric oxide (NO) in patients with chronic cough Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004